These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31019610)

  • 41. Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.
    Park S; Chu LC; Hruban RH; Vogelstein B; Kinzler KW; Yuille AL; Fouladi DF; Shayesteh S; Ghandili S; Wolfgang CL; Burkhart R; He J; Fishman EK; Kawamoto S
    Diagn Interv Imaging; 2020 Sep; 101(9):555-564. PubMed ID: 32278586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.
    Belousova E; Karmazanovsky G; Kriger A; Kalinin D; Mannelli L; Glotov A; Karelskaya N; Paklina O; Kaldarov A
    Clin Radiol; 2017 Feb; 72(2):150-158. PubMed ID: 27890421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
    Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
    Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Virtual monochromatic image at lower energy level for assessing pancreatic ductal adenocarcinoma in fast kV-switching dual-energy CT.
    Noda Y; Goshima S; Kaga T; Ando T; Miyoshi T; Kawai N; Kawada H; Tanahashi Y; Matsuo M
    Clin Radiol; 2020 Apr; 75(4):320.e17-320.e23. PubMed ID: 31879024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of computed tomography imaging features and pathological features of 41 patients with pancreatic neuroendocrine tumors.
    Utsumi M; Umeda Y; Takagi K; Takashi K; Nobuoka D; Yoshida R; Shinoura S; Sadamori H; Yagi T; Fujiwara T
    Hepatogastroenterology; 2015; 62(138):441-6. PubMed ID: 25916078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
    Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
    Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Cui W; Chen R; Guo K; Zhang H; Chen S; Wang Z
    Cancer Manag Res; 2019; 11():7857-7866. PubMed ID: 31686905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
    Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
    Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Okada A; Sugiura T; Tomoda K; Narumi Y; Nakamura H
    J Comput Assist Tomogr; 2002; 26(6):981-7. PubMed ID: 12488747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
    Kim SS; Kim SH; Song KD; Choi SY; Heo NH
    J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiation of pancreatic ductal adenocarcinoma from inflammatory mass: added value of magnetic resonance elastography.
    Liu Y; Wang M; Ji R; Cang L; Gao F; Shi Y
    Clin Radiol; 2018 Oct; 73(10):865-872. PubMed ID: 29895389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pancreatic Ductal Adenocarcinoma: Interface Enhancement Gradient Measured on Dual-Energy CT Images Improves Prognostic Evaluation.
    Amer AM; Li Y; Summerlin D; Burgan CM; McNamara MM; Smith AD; Morgan DE
    Radiol Imaging Cancer; 2020 Jul; 2(4):e190074. PubMed ID: 33778722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
    Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
    Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma.
    Ren S; Tang HJ; Zhao R; Duan SF; Chen R; Wang ZQ
    Curr Med Sci; 2022 Feb; 42(1):217-225. PubMed ID: 35089491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential Diagnosis of Nonhypervascular Pancreatic Neuroendocrine Neoplasms From Pancreatic Ductal Adenocarcinomas, Based on Computed Tomography Radiological Features and Texture Analysis.
    Yu H; Huang Z; Li M; Wei Y; Zhang L; Yang C; Zhang Y; Song B
    Acad Radiol; 2020 Mar; 27(3):332-341. PubMed ID: 31495760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PANCREATIC INCIDENTALOMA: DIFFERENTIATING NONFUNCTIONING PANCREATIC NEUROENDOCRINE TUMORS FROM INTRAPANCREATIC ACCESSORY SPLEEN.
    Osher E; Scapa E; Klausner J; Greenman Y; Tordjman K; Melhem A; Nachmany I; Sofer Y; Geva R; Blachar A; Stern N; Santo E
    Endocr Pract; 2016 Jul; 22(7):773-9. PubMed ID: 26919653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multi-institutional survey on imaging practice patterns in pancreatic ductal adenocarcinoma.
    Kambadakone AR; Zaheer A; Le O; Bhosale P; Meier J; Guimaraes AR; Shah Z; Hough DM; Mannelli L; Soloff E; Friedman A; Tamm E
    Abdom Radiol (NY); 2018 Feb; 43(2):245-252. PubMed ID: 29277858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pancreatic cysts: What imaging characteristics are associated with development of pancreatic ductal adenocarcinoma?
    Paroder V; Flusberg M; Kobi M; Rozenblit AM; Chernyak V
    Eur J Radiol; 2016 Sep; 85(9):1622-6. PubMed ID: 27501898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang J; Zhao R; Song L; Li H; Wang Z
    Abdom Radiol (NY); 2019 Mar; 44(3):867-876. PubMed ID: 30293109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.